公司在募投项目的实施过程中，严格遵守募集资金使用的有关规定，本着合理、节约、有效的原则，在 保证项目顺利实施的前提下，从项目资金使用的实际情况出发，审慎地使用募集资金，加强各个环节费 用的控制、监督和管理，对各项资源进行合理调度和优化，合理降低项目相关成本和费用，形成了募集 资金节余。 二、本次募投项目结项及募集资金节余情况 公司本次结项的募投项目为"病理数字化和智能化应用开发项目"，截止本公告披露日，计划投入募集资 金金额已按规定基本使用完毕，达到预定的主要研发目标。上述项目募集资金的使用及节余情况如下： ■ 注：最终实际转出金额以资金转出当日计算的该项目募集资金剩余金额为准。 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示： 一、募集资金基本情况 ■ 待节余募集资金转出完毕后，公司将办理销户手续，注销相关募集资金账户，公司与保荐机构、开户银 行签署的募集资金专户监管协议随之终止。 三、适用的审议程序及保荐人意见 根据《上海证券交易所科创板上市公司自律监管指引第1号一一规范运作》规定，单个或者全部募投项 目完成 ...

Group 1 - Yongtai Technology's wholly-owned subsidiary has received approval for trial production of a lithium battery additive project with an annual capacity of 5,000 tons, set to begin trial production [1] - Mengke Pharmaceutical has decided to terminate its plan to issue shares to a specific entity due to ongoing disagreements among major shareholders, which could impact the company's stable operations [1] - Anhui Construction's subsidiary has been approved to register and issue debt financing tools totaling 15 billion yuan, including 5 billion yuan in short-term financing notes and 10 billion yuan in medium-term notes [2] Group 2 - Koli'er plans to repurchase shares worth between 10 million and 20 million yuan, with a maximum repurchase price of 20.94 yuan per share, to implement an employee stock ownership plan [2] - Xinhua Pharmaceutical has received approval for the production of fumaric acid volnoral raw materials, which are used to treat gastroesophageal reflux disease [3] - Lianhuan Pharmaceutical has received approval for additional specifications of tadalafil tablets, expanding its product offerings for treating erectile dysfunction and benign prostatic hyperplasia [5] Group 3 - Greenland Holdings reported an increase of 1,834 lawsuits with a total amount of 6.587 billion yuan from October 21 to November 13, 2025 [7] - Lianke Technology plans to invest up to 600 million yuan of idle funds in low-risk financial products [8] - Yinglian Co. signed a strategic procurement contract for 5,000 million square meters of composite aluminum foil with a leading new energy technology company [10] Group 4 - China Eastern Airlines reported a 10.58% year-on-year increase in passenger turnover for October, with a capacity increase of 6.84% [12] - China National Airlines reported an 8.7% year-on-year increase in passenger turnover for October, with domestic and international capacity also showing growth [15] - Oupai Home plans to use 320 million yuan of idle funds to purchase structured deposits with expected annual yields between 0.65% and 2.50% [16] Group 5 - Tianwei Food has submitted H-share issuance application materials to the Hong Kong Stock Exchange, which have been accepted by the China Securities Regulatory Commission [18] - Guizhou Aviation plans to establish a subsidiary focused on the research, production, and market expansion of intelligent automotive components, with initial operating funds of 40 million yuan [20] - Daimai Co. plans to invest 100 million yuan to establish a wholly-owned subsidiary in Shanghai focused on robotics technology [22] Group 6 - Founder Securities has received approval to issue company bonds totaling up to 30 billion yuan [24] - Hengrui Medicine has received clinical trial approvals for multiple drugs, indicating ongoing research and development efforts [26] - Zhaojing Pharmaceutical's product ZG006 has received orphan drug designation from the FDA, providing various benefits for its development in the U.S. market [39]

格隆汇11月17日丨安必平(688393.SH)公布，公司本次结项的募投项目为"病理数字化和智能化应用开发 项目"，截止本公告披露日，计划投入募集资金金额已按规定基本使用完毕，达到预定的主要研发目 标。本次节余金额为30.32万元，下一步使用安排是拟将上述募投项目结项后的节余募集资金30.32万元 （实际金额以资金转出当日专户余额为准）永久补充流动资金，用于公司日常生产经营。 ...

二、本次募投项目结项及募集资金节余情况 证券代码：688393 证券简称：安必平 公告编号：2025-051 广州安必平医药科技股份有限公司 关于超募资金投资项目结项并将节余募集资金永久 补充流动资金的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 本次结项的募投项目名称：病理数字化和智能化应用开发项目 本次节余金额为 30.32 万元，下一步使用安排是拟将上述募投项目结 项后的节余募集资金 30.32 万元（实际金额以资金转出当日专户余额为准） 永久补充流动资金，用于公司日常生产经营。 一、募集资金基本情况 | 发行名称 | 2020 年首次公开发行股份 | | | --- | --- | --- | | 募集资金总额 | 71,327.04 | 万元 | | 募集资金净额 | 63,994.55 | 万元 | | 募集资金到账时间 | 2020 年 8 月 | 14 日 | 公司本次结项的募投项目为"病理数字化和智能化应用开发项目"，截止本 公告披露日，计划投入募集资金金额已按规定基本使用完毕，达到预 ...

股东大会法律意见书 i達律師事務所 UNDIAL LAW FIRM 中国深圳市福田区益田路 6001 号太平金融大厦 11、12 楼 邮编: 518038 11-12/F, TAIPING FINANCE TOWER, YITIAN ROAD 6001, FUTIAN DISTRICT, SHENZHEN, P.R. CHINA 电话(Tel):(0755)88265288 传真(Fax):(0755)88265537 电子邮件(E-mail): info@sundiallawfirm.com 网址(Website): www.sundiallawfirm.com 广东信达律师事务所 关于广州安必平医药科技股份有限公司 2025 年第二次临时股东大会的法律意见书 信达科会字(2025)第 055 号 致:广州安必平医药科技股份有限公司 广东信达律师事务所(以下简称"信达")接受广州安必平医药科技股份有 限公司(以下简称"公司")的委托,指派信达律师出席公司 2025年第二次临 时股东大会(以下简称"本次股东大会"),对本次股东大会的合法性进行见证, 并出具《广东信达律师事务所关于广州安必平医药科技股份有限公司 ...

广州安必平医药科技股份有限公司 证券代码：688393 证券简称：安必平 公告编号：2025-050 2025年第二次临时股东大会决议公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 本次会议是否有被否决议案：无 一、 会议召开和出席情况 （一） 股东大会召开的时间：2025 年 11 月 12 日 （二） 股东大会召开的地点：广州市黄埔区科信街 2 号公司会议室 （三） 出席会议的普通股股东、特别表决权股东、恢复表决权的优先股股东及 其持有表决权数量的情况： | 1、出席会议的股东和代理人人数 | 30 | | --- | --- | | 普通股股东人数 | 30 | | 2、出席会议的股东所持有的表决权数量 | 33,503,835 | | 普通股股东所持有表决权数量 | 33,503,835 | | 3、出席会议的股东所持有表决权数量占公司表决权数量的比 | 35.8071 | | 例（%） | | | 普通股股东所持有表决权数量占公司表决权数量的比例（%） | 35.8071 | （四） 表决方式 ...

Group 1 - Triangle Defense signed a gas turbine project development agreement and framework order agreement with Siemens Energy, allowing the company to qualify for supplying specific items to Siemens Energy [1] - The framework order agreement requires Triangle Defense to deliver products and tooling according to procurement orders and ensure quality standards [1] - Triangle Defense specializes in the research, production, sales, and service of forged products in the aerospace, aviation, and marine industries [1] Group 2 - Jindi Group reported a 65.78% year-on-year decline in signed amount for October, totaling 1.92 billion yuan, with a signed area of 184,000 square meters, down 53.30% year-on-year [2] - For the first ten months, Jindi Group's cumulative signed area was 1.976 million square meters, down 50.45%, and the signed amount was 26.1 billion yuan, down 55.33% [2] - Jindi Group is engaged in real estate development and sales, commercial real estate, and property management [2] Group 3 - Morning Light New Materials announced a plan for a shareholder to reduce holdings by up to 0.96% of the company's shares [3] - The reduction will occur through block trading starting from November 12, 2025 [3] - Morning Light New Materials focuses on the research, production, and sales of functional silanes and other silicon-based new materials [3] Group 4 - Sanjiang Shopping announced a plan for its second-largest shareholder to reduce holdings by up to 3% of the company's shares [4] - The reduction will take place through centralized bidding and block trading starting from November 27, 2025 [4] - Sanjiang Shopping specializes in the development and sales of community fresh supermarkets [5] Group 5 - Wen Tai Technology announced a plan for a shareholder to reduce holdings by up to 3% of the company's shares [11] - The reduction will occur through block trading and centralized bidding starting from November 27, 2025 [11] - Wen Tai Technology is involved in the research and development of mobile communication, semiconductors, and electronic components [11] Group 6 - Xi Ling Power announced a plan to acquire 100% equity of Weipai Automotive [18] - The acquisition involves cash payment and targets a company specializing in turbochargers, serving international automotive clients [18] - Xi Ling Power focuses on the research, production, and sales of automotive parts [18] Group 7 - Financial Securities plans to distribute a cash dividend of 0.6 yuan per 10 shares to all shareholders, totaling 276 million yuan [24] - The dividend distribution is based on the total share capital of 4.603 billion shares as of September 30, 2025 [24] - Financial Securities is engaged in wealth management, investment banking, and various securities-related businesses [24]

Core Viewpoint - Anbiping (688393.SH) announced a share reduction plan by major shareholders, indicating potential changes in shareholder structure and market sentiment [1] Group 1: Shareholder Actions - Major shareholders, including Zhuhai Gaotejia and its affiliates, plan to reduce their holdings by up to 935,676 shares, representing 1.00% of Anbiping's total share capital [1] - The reduction period is set for three months starting 15 trading days after the announcement [1] - As of the announcement date, these shareholders collectively hold 6,292,662 shares, accounting for 6.7253% of Anbiping's total shares [1] Group 2: Financial Performance - Anbiping reported a revenue of 253 million yuan for the first three quarters of 2025, a year-on-year decrease of 28.29% [2] - The company recorded a net loss attributable to shareholders of 10.77 million yuan, marking the fourth consecutive year of declining net profits [2] - Historical net profits from 2020 to 2024 were 84.75 million yuan, 79.78 million yuan, 42.69 million yuan, 40.06 million yuan, and 21.29 million yuan, respectively [2] Group 3: Initial Public Offering (IPO) Details - Anbiping raised a total of 713 million yuan from its IPO, with a net amount of 640 million yuan after deducting issuance costs [3] - The final net amount raised exceeded the original plan by 266 million yuan, which was initially set at 374 million yuan [3] - The IPO expenses totaled 73.32 million yuan, with underwriting fees amounting to 57.20 million yuan [3]

Core Viewpoint - Anping (688393) announced that certain shareholders plan to reduce their holdings through centralized bidding, potentially impacting the company's stock performance [1] Group 1 - The shareholders involved in the reduction plan include Zhuji Gaotejia, Chongqing Gaotejia, Hangzhou Gaotejia, and Hangzhou Ruihong [1] - The total number of shares to be reduced is up to 935,700 shares, which represents no more than 1% of the company's current total share capital [1]

Group 1 - Hualan Co., Ltd. plans to increase its shareholding by 30 million to 60 million yuan [1] - Kaili Medical's directors and executives collectively increased their holdings by 460,000 shares [1] - Zuming Co., Ltd.'s actual controller and shareholders plan to reduce their holdings by no more than 4% [1] Group 2 - Wentai Technology's Wuxi Guolian Integrated Circuit Investment Center intends to reduce its holdings by no more than 3% [1] - Kaimete Gas's shareholders plan to reduce their holdings by no more than 3% [1] - Kechuan Technology's Shi Huiqing intends to reduce his holdings by no more than 3% [1] Group 3 - Sanjiang Shopping's Alibaba Zhitai plans to reduce its holdings by no more than 3% [1] - Anbiping's Zhuji Gaotejia and its concerted parties plan to reduce their holdings by no more than 1% [1] - Tianyi Co., Ltd.'s controlling shareholder and specific shareholders plan to reduce their holdings by no more than 1% [1] Group 4 - Kangsong Co., Ltd.'s shareholder Jiangsu Ruijin plans to reduce his holdings by no more than 1% [1] - Ankai Bus's shareholders plan to reduce their holdings by no more than 1% [1] - Chenguang New Materials' Haojing Borui plans to reduce its holdings by no more than 0.96% [1] Group 5 - Hanbo High-tech's directors, executives, and shareholders plan to reduce their holdings by no more than 0.12% [1] - Chujian New Materials' directors plan to reduce their holdings by no more than 2 million shares [1]